News

Cycle Clarity is happy to announce our team will be hosting booth 2001 at the 77th ASRM Scientific Congress & Expo 2022, in Anaheim, California from October 22nd to October 26th. The team members attending are CEO, Dr. John Schnorr, COO, Chadd Clark, CFO, Susan...

After receiving FDA approval on January 19, 2022, a portion of the Cycle Clarity team appeared at The Donor Egg Meeting in Isle of Palms, SC for our first conference. The conference took place April 7th through April 10th where over 250 physicians, nurses, medical...

MyCycleClarity, powered by Follicle Clarity, is an artificial intelligence-based platform that delivers real-time measurements of each follicle within the ovary from a 10-second ultrasound. Beyond this, MyCycleClarity provides clinics with a prediction tool that has...

Cycle Clarity’s artificial intelligence software, Follicle Clarity, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). Follicle Clarity is a software application package that is designed to view and quantify image data acquired on...

While practicing Reproductive Endocrinology in Charleston South Carolina, an experienced Reproductive Endocrinologist, Dr. John Schnorr, identified patient and clinic challenges associated with monitoring egg production in patients undergoing fertility treatment. Egg...